C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
08/2011
08/16/2011	US7998461 Salmonella cancer therapeutics and related therapeutic methods
08/16/2011	CA2487095C Elongase genes and uses thereof
08/16/2011	CA2397590C Antisense inhibition of ptp1b expression
08/11/2011	WO2011097643A1 Selective reduction of allelic variants
08/11/2011	WO2011097641A1 Methods and compositions useful in treatment of diseases or conditions related to repeat expansion
08/11/2011	WO2011097640A1 Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
08/11/2011	WO2011097614A1 Mehods and compositions useful in diseases or conditions related to repeat expansion
08/11/2011	WO2011097527A2 Immunoprotection of therapeutic moieties using enhanced fc regions
08/11/2011	WO2011097492A1 A dna sequence that confers aphid resistance in soybean
08/11/2011	WO2011097092A2 Solid-supported ether disulfides
08/11/2011	WO2011095336A2 Post-synthetic modification of nucleic acids by inverse diels-alder reaction
08/11/2011	WO2011005861A9 Oligonucleotide end caps
08/11/2011	US20110197315 Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield
08/11/2011	US20110197310 Plants Tolerant to HPPD Inhibitor Herbicides
08/11/2011	US20110197309 Plants Tolerant to HPPD Inhibitor Herbicides
08/11/2011	US20110197308 Plants Tolerant to HPPD Inhibitor Herbicides
08/11/2011	US20110197307 Plants Tolerant to HPPD Inhibitor Herbicides
08/11/2011	US20110197305 Dense and erect panicle gene and uses thereof
08/11/2011	US20110197294 Compositions and methods for restoring mitochondrial electron transfer function
08/11/2011	US20110197293 Sense and antisense transcripts of trpm2 and uses thereof
08/11/2011	US20110197292 Delivery method
08/11/2011	US20110197291 Endoplasmic Reticulum Localization Signals
08/11/2011	US20110196180 Methods and compositions for producing olefins
08/11/2011	US20110196145 Process for desilylation of oligonucleotides
08/11/2011	US20110196144 Synthesis and use of 2'-substituted-n6-modified nucleosides
08/11/2011	US20110196143 DNA Encoding a Plant Lipase, Transgenic Plants and a Method for Controlling Senescence in Plants
08/11/2011	US20110196142 DNA molecule for expressing Hairpin RNA, the constructing method and the use thereof
08/11/2011	US20110196141 Locked and unlocked 2'-o phosphoramidite nucleosides, process of preparation thereof and oligomers comprising the nucleosides
08/11/2011	US20110196128 Murine zcytor17 ligand polynucleotides
08/11/2011	US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins
08/11/2011	US20110196020 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)
08/11/2011	US20110196016 Compositions and Methods for Inhibiting Expression of IKK2 Genes
08/11/2011	US20110195902 Fusion Protein Composed of Matrix Metalloproteinase-2 Inhibitor Peptide Derived From Amyloid-B Precursor Protein and Tissue Inhibitor of Metalloproteinase-2
08/11/2011	US20110195901 Artery- and vein-specific proteins and uses therefor
08/11/2011	US20110195895 Fgf21 mutants and uses thereof
08/11/2011	US20110195870 Method of combing a nucleic acid
08/11/2011	US20110195868 Methods and compositions for genetically detecting improved milk production traits in cattle
08/11/2011	US20110195863 Loss of Function mutations in KCNJ10 cause SeSAME, a human syndrome with sensory, neurological, and renal deficits
08/11/2011	US20110195843 Plants with Increased Yield (LT)
08/11/2011	US20110195512 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
08/11/2011	US20110195509 Treatment of th17-mediated autoimmune disease via inhibition of stat 3
08/11/2011	US20110195481 Variants And Compositions Comprising Variants With High Stability In Presence Of A Chelating Agent
08/11/2011	US20110195476 Modified chondroitin synthase polypeptide and crystal thereof
08/11/2011	US20110195455 Nucleic Acids Encoding Human Anti-IL-23 Antibodies
08/11/2011	US20110195453 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
08/11/2011	US20110195452 set of sequences for targeting expression and control of the post-translational modification of a recombinant polypeptide
08/11/2011	US20110195451 Protein Expression
08/11/2011	US20110195444 Novel protein having fructosyl valyl histidine oxidase activity, modified protein, and use of the protein or the modified protein
08/11/2011	US20110195426 Nucleic acids analysis
08/11/2011	US20110195412 Predictive Biomarkers for Response to Exercise
08/11/2011	US20110195409 Streptococcus pyogenes classification
08/11/2011	US20110195407 Nucleic acid occurring in blood from hepatitis patient, polypeptide encoded by the nucleic acid, and uses of the same
08/11/2011	US20110195155 Tannase, gene encoding same, and process for producing same
08/11/2011	US20110195113 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
08/11/2011	US20110195083 Cyclic v3 peptides for anti hiv-1 vaccine
08/11/2011	US20110195081 Foxm1 peptide and medicinal agent comprising the same
08/11/2011	US20110195077 Methods and compositions using fgf23 fusion ppolypeptides
08/11/2011	US20110195074 Ephrin Type-A Receptor 7 Protein
08/11/2011	US20110195072 Non-neuroendocrine cancer therapy
08/11/2011	US20110195069 Inhibitors of complement activation
08/11/2011	US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS
08/11/2011	US20110195062 Mammalian Cytokines; Related Reagents and Methods
08/11/2011	US20110195048 Regulation of lymphocytes and uses therefor
08/11/2011	US20110195027 Cd9-specific human antibodies
08/11/2011	US20110195022 Cd20 antibodies and uses thereof
08/11/2011	US20110195021 Cd20 antibodies and uses thereof
08/11/2011	DE102010007548A1 Microarray consisting of spots, at which mixture of polymerase and sequence specific primers is immobilized and coated with substrate, in which enzyme enabling sequence specific amplification is added, useful to genotype and quantify DNA
08/11/2011	DE102010007097A1 Konjugate aus [F-18]-Traegern mit bioaktiven, organischen Verbindungen und deren Darstellung Conjugates of [F-18] supports having bioactive organic compounds and their representation
08/11/2011	CA2789038A1 Selective reduction of allelic variants
08/11/2011	CA2789005A1 Selective reduction of allelic variants
08/10/2011	EP2354253A2 Method for non-invasive prenatal diagnosis
08/10/2011	EP2354250A1 Methods and nucleic acids for analyses of colorectal cell proliferative disorders
08/10/2011	EP2354249A1 Methods and nucleic acids for analyses of colorectal cell proliferative disorders
08/10/2011	EP2354248A1 Methods and nucleic acids for analyses of colorectal cell proliferative disorders
08/10/2011	EP2354148A2 Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof
08/10/2011	EP2353615A2 Compositions and methods for treating inflammatory lung disease
08/10/2011	EP2353614A1 Methods and immune modulatory nucleic acid compositions for preventing and treating disease
08/10/2011	EP2353389A1 Methods and compositions for treating disorders
08/10/2011	EP2352743A2 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
08/10/2011	EP2352527A1 Modulation of toll-like receptor 2 expression by antisense oligonucleotides
08/10/2011	EP1513958B1 Compositions for detecting hepatitis b virus
08/10/2011	EP1430157B1 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/10/2011	EP1412413B1 Synthesis and use of organosilica particles
08/10/2011	CN1980948B Treatment of diseases and conditions mediated by increased phosphorylation
08/10/2011	CN102149829A Imaging individual mRNA molecules using multiple singly labeled probes
08/10/2011	CN102149405A Influenza hemagglutinin and neuraminidase variants
08/10/2011	CN102146112A Method for extracting desoxyribonucleic acid from formalin fixed and paraffin embedded tissues
08/10/2011	CN102146111A New dinucleotide compound and preparation method thereof
08/10/2011	CN102145181A siRNA for inhibiting tumor growth and oligomeric nucleic acid combination and application of siRNA
08/10/2011	CN101717773B Method for extracting and purifying columnar high-purity animal mtDNA
08/10/2011	CN101565700B Reagent for extracting RNA or DNA virus in body fluid
08/10/2011	CN101148466B RNA disturbance target point for inhibiting MDV proliferating and application thereof
08/10/2011	CN101068919B Bacterial packaging strains usefuel for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof
08/09/2011	US7994309 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent
08/09/2011	US7994307 RNAi modulation of the BCR-ABL fusion gene and uses thereof
08/09/2011	US7994306 Methods of treating cancer using siRNA molecules directed against CD24
08/09/2011	US7994305 Small interfering RNA sequences for use in prevention and treatment of vision defects, inflammation, cardiovascular and cell proliferative disorders; RNA interference; gene expression inhibition
08/09/2011	US7994304 Sequencing nucleic acid molecules; promote accurate base-over-base incorporation in sequencing-by-synthesis reactions, resulting in greater read lengths
08/09/2011	US7994303 Penaeidin gene promoters in tiger shrimp and applications thereof
08/09/2011	US7994302 Fully human monoclonal antibodies to IL-13

1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 899